MAPK3 and prostate cancer: Further, it has been shown that β‐hCG promotes the invasion of prostate cancer cells by activating the expression of ERK1/2 and MMP‐2 and decreasing the expression of E‐cadherin in prostate cancer cells and showed poor prognosis of the disease.